Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ahmad Aljada

Showing results (21-30 of 90) with videos related to

Pageof 9
Sort By:
Metabolic Syndrome and Related Disorders|March 29, 2008
Classical Anti-oxidants (Scavengers) versus Biological Anti-oxidants (Suppressors of ROS Generation): ANovel Way to Explain the Anti-oxidant ParadoxParesh Dandona, Sandeep Dhindsa, Ahmad Aljada, et al.
Metabolic Syndrome and Related Disorders|March 29, 2008
Do thiazolidinediones exert their insulin-sensitizing effect through the suppression of free Fatty acids?Paresh Dandona, Sandeep Dhindsa, Husam Ghanim, et al.
Metabolism: Clinical and Experimental|March 26, 2002
Tumor necrosis factor-alpha inhibits insulin-induced increase in endothelial nitric oxide synthase and reduces insulin receptor content and phosphorylation in human aortic endothelial cellsAhmad Aljada, Husam Ghanim, Ezzat Assian, et al.
The Journal of Clinical Endocrinology and Metabolism|June 6, 2003
The potential influence of inflammation and insulin resistance on the pathogenesis and treatment of atherosclerosis-related complications in type 2 diabetesParesh Dandona, Ahmad Aljada, Ajay Chaudhuri, et al.
The Journal of Clinical Endocrinology and Metabolism|March 13, 2002
Insulin inhibits the pro-inflammatory transcription factor early growth response gene-1 (Egr)-1 expression in mononuclear cells (MNC) and reduces plasma tissue factor (TF) and plasminogen activator inhibitor-1 (PAI-1) concentrationsAhmad Aljada, Husam Ghanim, Priya Mohanty, et al.
Metabolic Syndrome and Related Disorders|March 29, 2008
Insulin Is an Anti-inflammatory and Anti-atherosclerotic HormoneParesh Dandona, Ahmad Aljada, Amy O'donnell, et al.
Metabolic Syndrome and Related Disorders|March 29, 2008
A novel view of metabolic syndromeParesh Dandona, Ahmad Aljada, Ajay Chaudhuri, et al.
The Journal of Clinical Investigation|August 3, 2005
Insulin infusion in acute illnessParesh Dandona, Priya Mohanty, Ajay Chaudhuri, et al.
Circulation|March 23, 2005
Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammationParesh Dandona, Ahmad Aljada, Ajay Chaudhuri, et al.
Angiogenesis|September 24, 2008
PPAR gamma ligands, rosiglitazone and pioglitazone, inhibit bFGF- and VEGF-mediated angiogenesisAhmad Aljada, Laura O'Connor, Yu-Yen Fu, et al.
Pageof 9

Showing results (21-30 of 90) with videos related to

Sort By:
Pageof 9
Metabolic Syndrome and Related Disorders|March 29, 2008
Classical Anti-oxidants (Scavengers) versus Biological Anti-oxidants (Suppressors of ROS Generation): ANovel Way to Explain the Anti-oxidant ParadoxParesh Dandona, Sandeep Dhindsa, Ahmad Aljada, et al.
Metabolic Syndrome and Related Disorders|March 29, 2008
Do thiazolidinediones exert their insulin-sensitizing effect through the suppression of free Fatty acids?Paresh Dandona, Sandeep Dhindsa, Husam Ghanim, et al.
Metabolism: Clinical and Experimental|March 26, 2002
Tumor necrosis factor-alpha inhibits insulin-induced increase in endothelial nitric oxide synthase and reduces insulin receptor content and phosphorylation in human aortic endothelial cellsAhmad Aljada, Husam Ghanim, Ezzat Assian, et al.
The Journal of Clinical Endocrinology and Metabolism|June 6, 2003
The potential influence of inflammation and insulin resistance on the pathogenesis and treatment of atherosclerosis-related complications in type 2 diabetesParesh Dandona, Ahmad Aljada, Ajay Chaudhuri, et al.
The Journal of Clinical Endocrinology and Metabolism|March 13, 2002
Insulin inhibits the pro-inflammatory transcription factor early growth response gene-1 (Egr)-1 expression in mononuclear cells (MNC) and reduces plasma tissue factor (TF) and plasminogen activator inhibitor-1 (PAI-1) concentrationsAhmad Aljada, Husam Ghanim, Priya Mohanty, et al.
Metabolic Syndrome and Related Disorders|March 29, 2008
Insulin Is an Anti-inflammatory and Anti-atherosclerotic HormoneParesh Dandona, Ahmad Aljada, Amy O'donnell, et al.
Metabolic Syndrome and Related Disorders|March 29, 2008
A novel view of metabolic syndromeParesh Dandona, Ahmad Aljada, Ajay Chaudhuri, et al.
The Journal of Clinical Investigation|August 3, 2005
Insulin infusion in acute illnessParesh Dandona, Priya Mohanty, Ajay Chaudhuri, et al.
Circulation|March 23, 2005
Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammationParesh Dandona, Ahmad Aljada, Ajay Chaudhuri, et al.
Angiogenesis|September 24, 2008
PPAR gamma ligands, rosiglitazone and pioglitazone, inhibit bFGF- and VEGF-mediated angiogenesisAhmad Aljada, Laura O'Connor, Yu-Yen Fu, et al.
Pageof 9